🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander in Early Adolescents

RecruitingNAAges 10 Years - 14 YearsAllMansoura University
NCT07739498 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled clinical trial aims to evaluate the effect of posterior disarticulatory resin bite turbos on the rate of maxillary expansion using a HYRAX expander in early adolescent patients. Participants will be randomly assigned to receive either maxillary expansion with posterior resin bite turbos or conventional expansion without bite turbos. The study will assess and compare the rate and effectiveness of maxillary expansion between the two groups during the treatment period. Clinical measurements will be recorded to evaluate skeletal and dental changes associated with the intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients aged 10-14 years. 2. Bilateral posterior cross bite. 3. Functional lateral cross bite. 4. Good general and oral health. 5. Normal to decreased vertical height )average FMA 29.7 °± 4.2 °).23 Exclusion Criteria: 1. Patients with cleft lip and palate. 2. Severe facial asymmetry. 3. Anterior open bite. 4. Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders). 5. Previous orthodontic treatment.
💊

What it tests

  • Intervention 1: HYRAX expander with posterior disarticulatory resin bite turbos
  • Intervention 2 (Control): HYRAX expander alone
📍

Where

1 site
Orthodontic Department - Faculty of Dentistry Mansoura University
Al Mansurah, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy